Intelligent Bio Solutions Inc. (INBS) announced a private placement with institutional investors for approximately $10.0 million. The placement includes shares of common stock, pre-funded warrants, and Series K-1 and K-2 warrants. The closing is expected on January 2, 2026, with proceeds going towards working capital and general corporate purposes. The securities are not registered under the Securities Act of 1933, and a registration statement will cover the resale of shares to investors. INBS’s Intelligent Fingerprinting Drug Screening System offers rapid, non-invasive testing for drug use, with applications in workplace safety and other industries.

For more information, visit: http://www.ibs.inc/
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
[email protected]

Read more at GlobeNewswire: Intelligent Bio Solutions Announces $10.0 Million Private